Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000013222
- Lead Sponsor
- Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)hypersensitivity to lixisenatide 2)patient with hypoglycemia 3)patient with serious liver and kidney disease 4)patient with proiferatibe retinopathy 5)during pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.MAGE by CGM 2.Glucose fluctuation by SMBG
- Secondary Outcome Measures
Name Time Method 1.change of C-peptide,glucagon and glucose during the meal test 2.frequency of hypoglycemia 3.frequency of adverse events